Novel vectors reduce the risks associated with ocular gene therapies

Novel vectors reduce the risks associated with ocular gene therapies

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindnes...
read more
American Academy of Ophthalmology, Nov. 13-15

American Academy of Ophthalmology, Nov. 13-15

The annual meeting of the American Academy of Opht...
read more